PEN Stock Chart & Stats
$5560.11
$0.00(0.00%)
―
--
Day’s Range― - ―
52-Week Range$4,191.95 - $5,560.11
Previous CloseN/A
VolumeN/A
Average Volume (3M)0.00
Market Cap
$219.19B
Enterprise Value$12.59K
Total Cash (Recent Filing)$241.29M
Total Debt (Recent Filing)$216.18M
Price to Earnings (P/E)72.8
Beta0.05
Next Earnings
Aug 04, 2026EPS Estimate
20.35Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)4.38
Shares Outstanding39,331,425
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)8.48
Price to Sales (P/S)8.62
P/FCF Ratio69.17
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)85.08
Revenue Forecast (FY)$27.63B
PEN FAQ
What was Penumbra Inc.’s price range in the past 12 months?
Penumbra Inc. lowest stock price was $4191.95 and its highest was $5560.11 in the past 12 months.
What is Penumbra Inc.’s market cap?
Penumbra Inc.’s market cap is $219.19B.
When is Penumbra Inc.’s upcoming earnings report date?
Penumbra Inc.’s upcoming earnings report date is Aug 04, 2026 which is in 9 days.
How were Penumbra Inc.’s earnings last quarter?
Penumbra Inc. released its earnings results on May 06, 2026. The company reported $14.357 earnings per share for the quarter, missing the consensus estimate of $18.174 by -$3.817.
Is Penumbra Inc. overvalued?
According to Wall Street analysts Penumbra Inc.’s price is currently Undervalued.
Does Penumbra Inc. pay dividends?
Penumbra Inc. does not currently pay dividends.
What is Penumbra Inc.’s EPS estimate?
Penumbra Inc.’s EPS estimate is 20.35.
How many shares outstanding does Penumbra Inc. have?
Penumbra Inc. has 39,331,425 shares outstanding.
What happened to Penumbra Inc.’s price movement after its last earnings report?
Penumbra Inc. reported an EPS of $14.357 in its last earnings report, missing expectations of $18.174. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Penumbra Inc.?
Currently, no hedge funds are holding shares in MX:PEN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Penumbra Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
MX:PEN Sentiment 70%
Sector Average 65%
Sector Average 65%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
36.20%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
19.15%
Trailing 12-Months
Company Description
Penumbra Inc.
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.